Fee* Effective CPT Code Short Description 02/15/2017

Size: px
Start display at page:

Download "Fee* Effective CPT Code Short Description 02/15/2017"

Transcription

1 90281 HUMAN IG, IM $ HUMAN IG, IV $ HUMAN IG, SC $ CMV IG, IV $1, HEP B IG, IM $ RABIES IG, IM/SC $ RABIES IG, HEAT TREATED $ RSV IG, IM, 50MG $1, RH IG, FULL-DOSE, IM $ RH IG, MINIDOSE, IM $ RH IG, IV $ TETANUS IG, IM $ ANTHRAX VACCINE, SC $ BCG VACCINE, PERCUT $ BCG VACCINE, INTRAVESICAL $ MENB RP W/OMV VACCINE IM $ MENB RLP VACCINE IM $ CHOLERA VACCINE LIVE ORAL $ FLU VACC IIV4 NO PRESERV ID $ HEP A VACCINE, ADULT IM $ HEP A VACC, PED/ADOL, 2 DOSE $ HEP A/HEP B VACC, ADULT IM $ MENINGOCCL HIB VAC 4 DOSE IM $ HIB VACCINE, PRP-OMP, IM $ HIB VACCINE, PRP-T, IM $ H PAPILLOMA VACC 3 DOSE IM $ H PAPILLOMA VACC 3 DOSE IM $ HPV VACCINE NON VALENT IM $ FLU VACCINE ADJUVANT IM $ FLU VACCINE NO PRESERV, INTRADERMAL $ FLU VACCINE NO PRESERV 3 & >, TRIVALENT $ FLU VACCINE AGE 3 & OVER, IM, TRIVALENT $ FLU VACCINE, NO PRESERV, ENHANCED IMMUNO $ PNEUMOCOCCAL CONJ VACC, 13 VALENT $ FLU VACCINE 4 VALENT NASAL $ FLU VACCINE, RIV3 PRSV FREE $ CCIIV4 VAC NO PRSV 0.5 ML IM $ RABIES VACCINE, IM $ ROTOVIRUS VACC 3 DOSE, ORAL $ ROTOVIRUS VACC 2 DOSE, ORAL $ FLU VAC NO PRSV 4 VAL 6-35 M $ FLU VAC NO PRSV 4 VAL 3 YRS+ $ FLU VACCINE 4 VAL 6-35 MO IM $ FLU VACC 4 VAL 3YRS PLUS IM $16.83 Page 1

2 90690 TYPHOID VACCINE, ORAL $ TYPHOID VACCINE, IM $ DTAP-IPV VACCINE, IM $ DTAP-HIB-IP VACCINE, IM $ DTAP VACCINE, < 7 YRS, IM $ DT VACCINE < 7, IM $ MMR VACCINE, SC $ MMRV VACCINE, SC $ POLIOVIRUS, IPV, SC/IM $ TD VACCINE NO PRSRV >/= 7 IM $ TDAP VACCINE >7 IM $ CHICKEN POX VACCINE, SC $ YELLOW FEVER VACCINE, SC $ DTAP-HEP B-IPV VACCINE, IM $ PNEUMOCOCCAL VACCINE $ MENINGOCOCCAL VACCINE, SC $ MENINGOCOCCAL VACCINE, IM $ ZOSTER VACC, SC $ INACTIVATED JE VACC IM $ HEPB VACC, ILL PAT 3 DOSE IM $ HEP B VACC, ADOL, 2 DOSE, IM $ HEPB VACC PED/ADOL 3 DOSE IM $ HEP B VACCINE, ADULT, 3 DOSE IM $ HEPB VACC, ILL PAT 4 DOSE IM $ HEP B/HIB VACCINE, IM $43.61 A9575 INJ GADOTERATE MEGLUMI 0.1ML $0.38 A9576 INJ PROHANCE MULTIPACK $1.53 A9577 INJ MULTIHANCE $2.30 A9578 INJ MULTIHANCE MULTIPACK $2.30 A9579 GAD-BASE MR CONTRAST NOS,1ML $1.91 A9581 GADOXETATE DISODIUM INJ $14.54 A9583 GADOFOSVESET TRISODIUM INJ $19.13 A9585 GADOBUTROL INJECTION $0.38 J0129 ABATACEPT INJECTION $48.20 J0130 ABCIXIMAB INJECTION $1, J0132 ACETYLCYSTEINE INJECTION $1.53 J0133 ACYCLOVIR INJECTION $0.38 J0135 ADALIMUMAB INJECTION $ J0153 ADENOSINE INJ 1MG $0.77 J0171 ADRENALIN EPINEPHRINE INJECT $0.38 J0178 AFLIBERCEPT INJECTION $1, J0180 AGALSIDASE BETA INJECTION $ J0202 INJECTION, ALEMTUZUMAB $1, J0207 AMIFOSTINE $ Page 2

3 J0221 LUMIZYME INJECTION $ J0256 ALPHA 1 PROTEINASE INHIBITOR $4.97 J0257 GLASSIA INJECTION $4.59 J0278 AMIKACIN SULFATE INJECTION $1.91 J0280 AMINOPHYLLIN 250 MG INJ $9.56 J0285 AMPHOTERICIN B $31.75 J0287 AMPHOTERICIN B LIPID COMPLEX $15.30 J0289 AMPHOTERICIN B LIPOSOME INJ $20.66 J0290 AMPICILLIN 500 MG INJ $1.15 J0295 AMPICILLIN SODIUM PER 1.5 GM $3.06 J0348 ANIDULAFUNGIN INJECTION $0.38 J0360 HYDRALAZINE HCL INJECTION $4.97 J0401 INJ ARIPIPRAZOLE EXT REL 1MG $4.97 J0456 AZITHROMYCIN $3.44 J0461 ATROPINE SULFATE INJECTION $0.38 J0470 DIMECAPROL INJECTION $47.43 J0475 BACLOFEN 10 MG INJECTION $ J0476 BACLOFEN INTRATHECAL TRIAL $80.33 J0480 BASILIXIMAB $3, J0485 BELATACEPT INJECTION $4.21 J0490 BELIMUMAB INJECTION $43.99 J0500 DICYCLOMINE INJECTION $72.68 J0515 INJ BENZTROPINE MESYLATE $27.16 J0558 PENG BENZATHINE/PROCAINE INJ $8.80 J0561 PENICILLIN G BENZATHINE INJ $11.09 J0570 BUPRENORPHINE IMPLANT 74.2MG $1, J0583 BIVALIRUDIN $1.53 J0585 INJECTION,ONABOTULINUMTOXINA $6.12 J0586 ABOBOTULINUMTOXINA $8.03 J0587 INJ, RIMABOTULINUMTOXINB $12.24 J0588 INCOBOTULINUMTOXIN A $4.97 J0592 BUPRENORPHINE HYDROCHLORIDE $3.44 J0594 BUSULFAN INJECTION $39.02 J0595 BUTORPHANOL TARTRATE 1 MG $2.68 J0597 C-1 ESTERASE, BERINERT $48.96 J0598 C-1 ESTERASE, CINRYZE $58.14 J0600 EDETATE CALCIUM DISODIUM INJ $5, J0610 CALCIUM GLUCONATE INJECTION $3.83 J0630 CALCITONIN SALMON INJECTION $2, J0636 INJ CALCITRIOL PER 0.1 MCG $0.38 J0637 CASPOFUNGIN ACETATE $12.24 J0638 CANAKINUMAB INJECTION $97.16 J0640 LEUCOVORIN CALCIUM INJECTION $3.06 J0641 LEVOLEUCOVORIN INJECTION $0.77 Page 3

4 J0670 INJ MEPIVACAINE HCL/10 ML $2.68 J0690 CEFAZOLIN SODIUM INJECTION $1.15 J0692 CEFEPIME HCL FOR INJECTION $2.68 J0694 CEFOXITIN SODIUM INJECTION $4.59 J0696 CEFTRIAXONE SODIUM INJECTION $0.77 J0697 STERILE CEFUROXIME INJECTION $2.68 J0698 CEFOTAXIME SODIUM INJECTION $1.53 J0702 BETAMETHASONE ACET&SOD PHOSP $6.50 J0712 CEFTAROLINE FOSAMIL INJ $2.68 J0713 INJ CEFTAZIDIME PER 500 MG $2.30 J0717 CERTOLIZUMAB PEGOL INJ 1MG $7.65 J0720 CHLORAMPHENICOL SODIUM INJEC $42.08 J0725 CHORIONIC GONADOTROPIN/1000U $25.25 J0735 CLONIDINE HYDROCHLORIDE $14.15 J0740 CIDOFOVIR INJECTION $ J0743 CILASTATIN SODIUM INJECTION $7.27 J0744 CIPROFLOXACIN IV $1.53 J0770 COLISTIMETHATE SODIUM INJ $11.48 J0775 COLLAGENASE, CLOST HIST INJ $43.22 J0780 PROCHLORPERAZINE INJECTION $12.62 J0795 CORTICORELIN OVINE TRIFLUTAL $8.42 J0800 CORTICOTROPIN INJECTION $3, J0834 COSYNTROPIN CORTROSYN INJ $40.16 J0840 CROTALIDAE POLY IMMUNE FAB $2, J0850 CYTOMEGALOVIRUS IMM IV /VIAL $1, J0875 INJECTION, DALBAVANCIN $15.68 J0878 DAPTOMYCIN INJECTION $0.77 J0881 DARBEPOETIN ALFA, NON-ESRD $4.21 J0882 DARBEPOETIN ALFA, ESRD USE $4.21 J0885 EPOETIN ALFA, NON-ESRD $13.01 J0887 EPOETIN BETA ESRD USE $1.53 J0888 EPOETIN BETA NON ESRD $1.53 J0894 DECITABINE INJECTION $20.66 J0895 DEFEROXAMINE MESYLATE INJ $9.18 J0897 DENOSUMAB INJECTION $17.21 J1000 DEPO-ESTRADIOL CYPIONATE INJ $18.74 J1020 METHYLPREDNISOLONE 20 MG INJ $5.36 J1030 METHYLPREDNISOLONE 40 MG INJ $5.74 J1040 METHYLPREDNISOLONE 80 MG INJ $10.71 J1050 MEDROXYPROGESTERONE ACETATE $0.38 J1071 INJ TESTOSTERONE CYPIONATE $0.38 J1100 DEXAMETHASONE SODIUM PHOS $0.38 J1110 INJ DIHYDROERGOTAMINE MESYLT $ J1120 ACETAZOLAMID SODIUM INJECTIO $20.66 Page 4

5 J1160 DIGOXIN INJECTION $8.80 J1162 DIGOXIN IMMUNE FAB (OVINE) $3, J1165 PHENYTOIN SODIUM INJECTION $0.77 J1170 HYDROMORPHONE INJECTION $2.30 J1190 DEXRAZOXANE HCL INJECTION $ J1200 DIPHENHYDRAMINE HCL INJECTIO $0.77 J1205 CHLOROTHIAZIDE SODIUM INJ $88.74 J1212 DIMETHYL SULFOXIDE 50% 50 ML $ J1230 METHADONE INJECTION $19.89 J1240 DIMENHYDRINATE INJECTION $8.03 J1245 DIPYRIDAMOLE INJECTION $0.77 J1250 INJ DOBUTAMINE HCL/250 MG $5.74 J1265 DOPAMINE INJECTION $0.38 J1267 DORIPENEM INJECTION $0.77 J1270 INJECTION, DOXERCALCIFEROL $0.77 J1290 ECALLANTIDE INJECTION $ J1300 ECULIZUMAB INJECTION $ J1325 EPOPROSTENOL INJECTION $16.45 J1335 ERTAPENEM INJECTION $51.26 J1364 ERYTHRO LACTOBIONATE /500 MG $62.73 J1380 ESTRADIOL VALERATE 10 MG INJ $17.98 J1410 INJ ESTROGEN CONJUGATE 25 MG $ J1430 ETHANOLAMINE OLEATE 100 MG $ J1439 INJ FERRIC CARBOXYMALTOS 1MG $1.15 J1442 INJ FILGRASTIM EXCL BIOSIMIL $1.15 J1447 INJ TBO FILGRASTIM 1 MICROG $0.77 J1450 FLUCONAZOLE $4.59 J1453 FOSAPREPITANT INJECTION $1.91 J1458 GALSULFASE INJECTION $ J1459 INJ IVIG PRIVIGEN 500 MG $40.55 J1460 GAMMA GLOBULIN 1 CC INJ $37.49 J1556 INJ, IMM GLOB BIVIGAM, 500MG $39.02 J1557 GAMMAPLEX INJECTION $40.93 J1559 HIZENTRA INJECTION $10.33 J1560 GAMMA GLOBULIN > 10 CC INJ $ J1561 GAMUNEX-C/GAMMAKED $38.25 J1566 IMMUNE GLOBULIN, POWDER $33.66 J1568 OCTAGAM INJECTION $37.10 J1569 GAMMAGARD LIQUID INJECTION $42.08 J1570 GANCICLOVIR SODIUM INJECTION $64.64 J1571 HEPAGAM B IM INJECTION $61.58 J1572 FLEBOGAMMA INJECTION $34.43 J1575 HYQVIA 100MG IMMUNEGLOBULIN $13.77 J1580 GARAMYCIN GENTAMICIN INJ $1.53 Page 5

6 J1602 GOLIMUMAB FOR IV USE 1MG $25.63 J1610 GLUCAGON HYDROCHLORIDE/1 MG $ J1626 GRANISETRON HCL INJECTION $0.38 J1630 HALOPERIDOL INJECTION $0.77 J1631 HALOPERIDOL DECANOATE INJ $18.74 J1640 HEMIN, 1 MG $24.10 J1642 INJ HEPARIN SODIUM PER 10 U $0.38 J1644 INJ HEPARIN SODIUM PER 1000U $0.38 J1645 DALTEPARIN SODIUM $16.83 J1650 INJ ENOXAPARIN SODIUM $0.77 J1652 FONDAPARINUX SODIUM $2.30 J1670 TETANUS IMMUNE GLOBULIN INJ $ J1720 HYDROCORTISONE SODIUM SUCC I $9.56 J1725 INJECTION HPC 1 MG (MAKENA) $3.06 J1740 IBANDRONATE SODIUM INJECTION $ J1742 IBUTILIDE FUMARATE INJECTION $ J1743 IDURSULFASE INJECTION $ J1745 INFLIXIMAB NOT BIOSIMIL 10MG $86.06 J1750 INJ IRON DEXTRAN $13.01 J1756 IRON SUCROSE INJECTION $0.38 J1786 IMUGLUCERASE INJECTION $43.99 J1800 PROPRANOLOL INJECTION $1.91 J1815 INSULIN INJECTION $0.77 J1817 INSULIN FOR INSULIN PUMP USE $10.33 J1885 KETOROLAC TROMETHAMINE INJ $0.77 J1930 LANREOTIDE INJECTION $54.70 J1931 LARONIDASE INJECTION $32.13 J1940 FUROSEMIDE INJECTION $1.53 J1950 LEUPROLIDE ACETATE /3.75 MG $1, J1953 LEVETIRACETAM INJECTION $0.38 J1955 INJ LEVOCARNITINE PER 1 GM $21.80 J1956 LEVOFLOXACIN INJECTION $1.53 J1980 HYOSCYAMINE SULFATE INJ $29.07 J2001 LIDOCAINE INJECTION $0.38 J2010 LINCOMYCIN INJECTION $12.62 J2020 LINEZOLID INJECTION $16.83 J2060 LORAZEPAM INJECTION $0.77 J2150 MANNITOL INJECTION $2.30 J2175 MEPERIDINE HYDROCHL /100 MG $4.97 J2185 MEROPENEM $1.53 J2210 METHYLERGONOVIN MALEATE INJ $8.03 J2248 MICAFUNGIN SODIUM INJECTION $1.15 J2250 INJ MIDAZOLAM HYDROCHLORIDE $0.38 J2270 MORPHINE SULFATE INJECTION $1.91 Page 6

7 J2274 IN MORPHINE PRESERVATIV FREE $10.33 J2278 ZICONOTIDE INJECTION $7.65 J2280 INJ, MOXIFLOXACIN 100 MG $8.80 J2300 INJ NALBUPHINE HYDROCHLORIDE $2.68 J2310 INJ NALOXONE HYDROCHLORIDE $30.60 J2315 NALTREXONE, DEPOT FORM $3.44 J2323 NATALIZUMAB INJECTION $19.51 J2353 OCTREOTIDE INJECTION, DEPOT $ J2354 OCTREOTIDE INJ, NON-DEPOT $1.15 J2355 OPRELVEKIN INJECTION $ J2357 OMALIZUMAB INJECTION $34.04 J2358 OLANZAPINE LONG-ACTING INJ $3.06 J2360 ORPHENADRINE INJECTION $3.83 J2400 CHLOROPROCAINE HCL INJECTION $28.69 J2405 ONDANSETRON HCL INJECTION $0.38 J2407 INJECTION, ORITAVANCIN $26.01 J2410 OXYMORPHONE HCL INJECTION $3.06 J2425 PALIFERMIN INJECTION $18.36 J2426 PALIPERIDONE PALMITATE INJ $9.95 J2430 PAMIDRONATE DISODIUM /30 MG $10.71 J2469 PALONOSETRON HCL $23.72 J2501 PARICALCITOL $1.15 J2503 PEGAPTANIB SODIUM INJECTION $1, J2504 PEGADEMASE BOVINE, 25 IU $ J2505 INJECTION, PEGFILGRASTIM 6MG $4, J2507 PEGLOTICASE INJECTION $1, J2510 PENICILLIN G PROCAINE INJ $29.45 J2515 PENTOBARBITAL SODIUM INJ $52.02 J2540 PENICILLIN G POTASSIUM INJ $1.15 J2543 PIPERACILLIN/TAZOBACTAM $2.68 J2545 PENTAMIDINE NON-COMP UNIT $ J2550 PROMETHAZINE HCL INJECTION $2.30 J2560 PHENOBARBITAL SODIUM INJ $30.98 J2562 PLERIXAFOR INJECTION $ J2597 INJ DESMOPRESSIN ACETATE $14.15 J2675 INJ PROGESTERONE PER 50 MG $1.53 J2680 FLUPHENAZINE DECANOATE 25 MG $22.57 J2690 PROCAINAMIDE HCL INJECTION $58.91 J2700 OXACILLIN SODIUM INJECITON $1.91 J2704 INJ, PROPOFOL, 10 MG $0.38 J2720 INJ PROTAMINE SULFATE/10 MG $1.15 J2724 PROTEIN C CONCENTRATE $16.07 J2765 METOCLOPRAMIDE HCL INJECTION $0.77 J2770 QUINUPRISTIN/DALFOPRISTIN $ Page 7

8 J2778 RANIBIZUMAB INJECTION $ J2780 RANITIDINE HYDROCHLORIDE INJ $1.15 J2783 RASBURICASE $ J2785 REGADENOSON INJECTION $58.14 J2788 RHO D IMMUNE GLOBULIN 50 MCG $26.39 J2790 RHO D IMMUNE GLOBULIN INJ $84.15 J2791 RHOPHYLAC INJECTION $4.97 J2792 RHO(D) IMMUNE GLOBULIN H, SD $23.33 J2794 RISPERIDONE, LONG ACTING $8.42 J2795 ROPIVACAINE HCL INJECTION $0.38 J2796 ROMIPLOSTIM INJECTION $67.32 J2800 METHOCARBAMOL INJECTION $40.93 J2805 SINCALIDE INJECTION $ J2810 INJ THEOPHYLLINE PER 40 MG $0.38 J2820 SARGRAMOSTIM INJECTION $39.02 J2850 INJ SECRETIN SYNTHETIC HUMAN $36.34 J2916 NA FERRIC GLUCONATE COMPLEX $2.30 J2920 METHYLPREDNISOLONE INJECTION $4.21 J2930 METHYLPREDNISOLONE INJECTION $5.74 J2997 ALTEPLASE RECOMBINANT $85.30 J3000 STREPTOMYCIN INJECTION $13.39 J3010 FENTANYL CITRATE INJECITON $0.38 J3060 INJ, TALIGLUCERACE ALFA 10 U $42.46 J3070 PENTAZOCINE INJECTION $ J3090 INJ TEDIZOLID PHOSPHATE $1.15 J3095 TELAVANCIN INJECTION $5.36 J3101 TENECTEPLASE INJECTION $ J3105 TERBUTALINE SULFATE INJ $3.44 J3121 INJ TESTOSTERO ENANTHATE 1MG $0.38 J3230 CHLORPROMAZINE HCL INJECTION $25.63 J3240 THYROTROPIN INJECTION $1, J3243 TIGECYCLINE INJECTION $3.44 J3250 TRIMETHOBENZAMIDE HCL INJ $28.31 J3260 TOBRAMYCIN SULFATE INJECTION $2.30 J3262 TOCILIZUMAB INJECTION $4.59 J3285 TREPROSTINIL INJECTION $64.26 J3300 TRIAMCINOLONE A INJ PRS-FREE $3.83 J3301 TRIAMCINOLONE ACET INJ NOS $1.91 J3303 TRIAMCINOLONE HEXACETONL INJ $3.83 J3315 TRIPTORELIN PAMOATE $ J3357 USTEKINUMAB SUB CU INJ, 1 MG $ J3360 DIAZEPAM INJECTION $9.95 J3370 VANCOMYCIN HCL INJECTION $3.06 J3380 INJECTION, VEDOLIZUMAB $18.36 Page 8

9 J3385 VELAGLUCERASE ALFA $ J3396 VERTEPORFIN INJECTION $11.09 J3410 HYDROXYZINE HCL INJECTION $2.30 J3411 THIAMINE HCL 100 MG $3.44 J3415 PYRIDOXINE HCL 100 MG $12.62 J3420 VITAMIN B12 INJECTION $4.21 J3430 VITAMIN K PHYTONADIONE INJ $3.83 J3465 INJECTION, VORICONAZOLE $3.83 J3471 OVINE, UP TO 999 USP UNITS $0.38 J3473 HYALURONIDASE RECOMBINANT $0.38 J3475 INJ MAGNESIUM SULFATE $0.38 J3480 INJ POTASSIUM CHLORIDE $0.38 J3485 ZIDOVUDINE $1.53 J3486 ZIPRASIDONE MESYLATE $21.04 J3489 ZOLEDRONIC ACID 1MG $13.01 J7030 NORMAL SALINE SOLUTION INFUS $1.91 J7040 NORMAL SALINE SOLUTION INFUS $1.15 J7042 5% DEXTROSE/NORMAL SALINE $0.77 J7050 NORMAL SALINE SOLUTION INFUS $0.38 J7060 5% DEXTROSE/WATER $1.91 J7070 D5W INFUSION $3.83 J7120 RINGERS LACTATE INFUSION $2.30 J7180 FACTOR XIII ANTI-HEM FACTOR $8.42 J7182 FACTOR VIII RECOMB NOVOEIGHT $1.53 J7183 WILATE INJECTION $1.15 J7185 XYNTHA INJ $1.15 J7186 ANTIHEMOPHILIC VIII/VWF COMP $1.15 J7187 HUMATE-P, INJ $1.15 J7189 FACTOR VIIA $1.91 J7190 FACTOR VIII $1.15 J7192 FACTOR VIII RECOMBINANT NOS $1.15 J7193 FACTOR IX NON-RECOMBINANT $1.15 J7194 FACTOR IX COMPLEX $1.53 J7195 FACTOR IX RECOMBINANT NOS $1.53 J7197 ANTITHROMBIN III INJECTION $3.44 J7198 ANTI-INHIBITOR $1.91 J7200 FACTOR IX RECOMBINAN RIXUBIS $1.15 J7201 FACTOR IX ALPROLIX RECOMB $3.06 J7205 FACTOR VIII FC FUSION RECOMB $1.91 J7297 LEVONORGESTREL IU CONTRACEPTIVE, 52MG, 3 YEAR $ J7298 LEVONORGESTREL IU CONTRACEPTIVE, 52MG, 5 YEAR $ J7300 INTRAUT COPPER CONTRACEPTIVE $ J7301 LEVONORGESTREL IU CONTRACEPTIVE, (SKYLA) $ J7307 ETONOGESTREL IMPLANT SYSTEM $ Page 9

10 J7308 AMINOLEVULINIC ACID HCL TOP $ J7311 FLUOCINOLONE ACETONIDE IMPLT $21, J7312 DEXAMETHASONE INTRA IMPLANT $ J7313 FLUOCINOL ACET INTRAVIT IMP $ J7316 INJ, OCRIPLASMIN, MG $1, J7320 GENVISC 850, INJ, 1MG $8.42 J7321 HYALGAN/SUPARTZ INJ PER DOSE $90.27 J7323 EUFLEXXA INJ PER DOSE $ J7324 ORTHOVISC INJ PER DOSE $ J7325 SYNVISC OR SYNVISC-ONE $13.77 J7326 GEL-ONE $ J7327 MONOVISC INJ PER DOSE $ J7336 CAPSAICIN 8% PATCH $3.06 J7500 AZATHIOPRINE ORAL 50MG $0.38 J7502 CYCLOSPORINE ORAL 100 MG $3.06 J7503 TACROL ENVARSUS EX REL ORAL $1.15 J7504 LYMPHOCYTE IMMUNE GLOBULIN $1, J7507 TACROLIMUS IMME REL ORAL 1MG $0.77 J7508 TACROL ASTAGRAF EX REL ORAL $0.38 J7509 METHYLPREDNISOLONE ORAL $0.38 J7510 PREDNISOLONE ORAL PER 5 MG $0.38 J7511 ANTITHYMOCYTE GLOBULN RABBIT $ J7512 PREDNISONE IR OR DR ORAL 1MG $0.38 J7515 CYCLOSPORINE ORAL 25 MG $0.77 J7516 CYCLOSPORIN PARENTERAL 250MG $42.46 J7517 MYCOPHENOLATE MOFETIL ORAL $1.15 J7518 MYCOPHENOLIC ACID $3.06 J7520 SIROLIMUS, ORAL $8.42 J7525 TACROLIMUS INJECTION $ J7527 ORAL EVEROLIMUS $8.42 J7605 ARFORMOTEROL NON-COMP UNIT $9.95 J7606 FORMOTEROL FUMARATE, INH $11.09 J7608 ACETYLCYSTEINE NON-COMP UNIT $4.59 J7611 ALBUTEROL NON-COMP CON $0.38 J7612 LEVALBUTEROL NON-COMP CON $0.38 J7613 ALBUTEROL NON-COMP UNIT $0.38 J7614 LEVALBUTEROL NON-COMP UNIT $0.38 J7620 ALBUTEROL IPRATROP NON-COMP $0.38 J7626 BUDESONIDE NON-COMP UNIT $2.68 J7631 CROMOLYN SODIUM NONCOMP UNIT $0.77 J7639 DORNASE ALFA NON-COMP UNIT $44.75 J7644 IPRATROPIUM BROMIDE NON-COMP $0.38 J7674 METHACHOLINE CHLORIDE, NEB $0.38 J7682 TOBRAMYCIN NON-COMP UNIT $46.28 Page 10

11 J7686 TREPROSTINIL, NON-COMP UNIT $ J8501 ORAL APREPITANT $13.01 J8510 ORAL BUSULFAN $24.86 J8520 CAPECITABINE, ORAL, 150 MG $4.21 J8521 CAPECITABINE, ORAL, 500 MG $12.62 J8530 CYCLOPHOSPHAMIDE ORAL 25 MG $3.44 J8540 ORAL DEXAMETHASONE $0.38 J8560 ETOPOSIDE ORAL 50 MG $77.27 J8600 MELPHALAN ORAL 2 MG $12.24 J8610 METHOTREXATE ORAL 2.5 MG $0.77 J8655 NETUPITANT PALONOSETRON ORAL $ J8700 TEMOZOLOMIDE $1.91 J8705 TOPOTECAN ORAL $ J9000 DOXORUBICIN HCL INJECTION $2.68 J9017 ARSENIC TRIOXIDE INJECTION $68.09 J9019 ERWINAZE INJECTION $ J9025 AZACITIDINE INJECTION $2.68 J9027 CLOFARABINE INJECTION $ J9031 BCG LIVE INTRAVESICAL VAC $ J9032 INJECTION, BELINOSTAT, 10MG $36.34 J9033 INJ., TREANDA 1 MG $29.45 J9034 INJ., BENDEKA 1 MG $24.86 J9035 BEVACIZUMAB INJECTION $77.27 J9040 BLEOMYCIN SULFATE INJECTION $52.79 J9041 BORTEZOMIB INJECTION $48.58 J9042 BRENTUXIMAB VEDOTIN INJ $ J9043 CABAZITAXEL INJECTION $ J9045 CARBOPLATIN INJECTION $3.83 J9047 INJECTION, CARFILZOMIB, 1 MG $33.28 J9050 CARMUSTINE INJECTION $4, J9055 CETUXIMAB INJECTION $59.29 J9060 CISPLATIN 10 MG INJECTION $2.30 J9065 INJ CLADRIBINE PER 1 MG $24.48 J9070 CYCLOPHOSPHAMIDE 100 MG INJ $44.37 J9098 CYTARABINE LIPOSOME INJ $ J9100 CYTARABINE HCL 100 MG INJ $0.77 J9120 DACTINOMYCIN INJECTION $1, J9130 DACARBAZINE 100 MG INJ $4.59 J9145 INJECTION, DARATUMUMAB 10 MG $49.34 J9150 DAUNORUBICIN INJECTION $32.90 J9155 DEGARELIX INJECTION $3.83 J9171 DOCETAXEL INJECTION $2.68 J9176 INJECTION, ELOTUZUMAB, 1MG $6.50 J9178 INJ, EPIRUBICIN HCL, 2 MG $1.53 Page 11

12 J9179 ERIBULIN MESYLATE INJECTION $ J9181 ETOPOSIDE INJECTION $0.77 J9185 FLUDARABINE PHOSPHATE INJ $62.73 J9190 FLUOROURACIL INJECTION $1.91 J9200 FLOXURIDINE INJECTION $78.41 J9201 GEMCITABINE HCL INJECTION $5.74 J9202 GOSERELIN ACETATE IMPLANT $ J9205 INJ IRINOTECAN LIPOSOME 1 MG $41.31 J9206 IRINOTECAN INJECTION $3.83 J9207 IXABEPILONE INJECTION $80.33 J9208 IFOSFAMIDE INJECTION $29.84 J9209 MESNA INJECTION $1.91 J9211 IDARUBICIN HCL INJECTION $35.96 J9214 INTERFERON ALFA-2B INJ $27.92 J9217 LEUPROLIDE ACETATE SUSPNSION $ J9218 LEUPROLIDE ACETATE INJECITON $23.72 J9225 VANTAS IMPLANT $3, J9226 SUPPRELIN LA IMPLANT $29, J9228 IPILIMUMAB INJECTION $ J9230 MECHLORETHAMINE HCL INJ $ J9245 INJ MELPHALAN HYDROCHL 50 MG $2, J9250 METHOTREXATE SODIUM INJ $0.38 J9260 METHOTREXATE SODIUM INJ $2.30 J9261 NELARABINE INJECTION $ J9263 OXALIPLATIN $0.38 J9264 PACLITAXEL PROTEIN BOUND $10.71 J9266 PEGASPARGASE INJECTION $14, J9267 PACLITAXEL INJECTION $0.38 J9268 PENTOSTATIN INJECTION $1, J9271 INJ PEMBROLIZUMAB $48.96 J9280 MITOMYCIN INJECTION $ J9293 MITOXANTRONE HYDROCHL / 5 MG $41.31 J9295 INJECTION, NECITUMUMAB, 1 MG $5.36 J9299 INJECTION, NIVOLUMAB $27.16 J9301 OBINUTUZUMAB INJ $60.05 J9302 OFATUMUMAB INJECTION $55.85 J9303 PANITUMUMAB INJECTION $ J9305 PEMETREXED INJECTION $66.94 J9306 INJECTION, PERTUZUMAB, 1 MG $11.48 J9307 PRALATREXATE INJECTION $ J9308 INJECTION, RAMUCIRUMAB $59.29 J9310 RITUXIMAB INJECTION $ J9315 ROMIDEPSIN INJECTION $ J9320 STREPTOZOCIN INJECTION $ Page 12

13 J9325 INJ TALIMOGENE LAHERPAREPVEC $48.58 J9328 TEMOZOLOMIDE INJECTION $8.42 J9330 TEMSIROLIMUS INJECTION $71.15 J9351 TOPOTECAN INJECTION $1.15 J9352 INJECTION TRABECTEDIN 0.1MG $ J9354 INJ, ADO-TRASTUZUMAB EMT 1MG $30.98 J9355 TRASTUZUMAB INJECTION $99.07 J9357 VALRUBICIN INJECTION $1, J9360 VINBLASTINE SULFATE INJ $3.83 J9370 VINCRISTINE SULFATE 1 MG INJ $4.59 J9371 INJ, VINCRISTINE SUL LIP 1MG $2, J9390 VINORELBINE TARTRATE INJ $9.18 J9395 INJECTION, FULVESTRANT $ J9400 INJ, ZIV-AFLIBERCEPT, 1MG $8.42 P9041 ALBUMIN (HUMAN),5%, 50ML $11.86 P9045 ALBUMIN (HUMAN), 5%, 250 ML $57.38 P9046 ALBUMIN (HUMAN), 25%, 20 ML $23.72 P9047 ALBUMIN (HUMAN), 25%, 50ML $56.23 Q0138 FERUMOXYTOL, NON-ESRD $0.77 Q0139 FERUMOXYTOL, ESRD USE $0.77 Q0162 ONDANSETRON ORAL $0.38 Q0163 DIPHENHYDRAMINE HCL 50MG $0.38 Page 13

Table III: 2019 Medicare Drug Fee Schedule* CY st Quarter Average Sales Price (ASP) Data Plus 6 Percent

Table III: 2019 Medicare Drug Fee Schedule* CY st Quarter Average Sales Price (ASP) Data Plus 6 Percent Table III: 2019 Medicare Drug Fee Schedule* CY 2019 1st Quarter Average Sales Price (ASP) Data Plus 6 Percent *The Medicare payments allowance limits are effective Jan. 1 thru March. 31, 2019. CY 2019

More information

The following are J Code requirements

The following are J Code requirements The following are J Code requirements J Codes 20610 Arthrocentesis, aspiration and/or injection; major joint or bursa (eg, shoulder, hip, knee joint, subacromial bursa) A9579 Injection, gadolinium based

More information

Vivida Health Specialty Pharmacy Drugs (Injectable) Prior-Authorization Requirements Effective 1/1/19

Vivida Health Specialty Pharmacy Drugs (Injectable) Prior-Authorization Requirements Effective 1/1/19 Vivida Health Specialty Pharmacy Drugs (Injectable) Prior-Authorization Requirements Effective 1/1/19 All Non-Par Provider Requests Requires Authorization Regardless of Service J0178 J0180 J0202 J0205

More information

Fee* Effective CPT Code Short Description

Fee* Effective CPT Code Short Description 90281 HUMAN IG, IM $70.38 90283 HUMAN IG, IV $42.84 90284 HUMAN IG, SC $10.71 90291 CMV IG, IV $1,311.21 90371 HEP B IG, IM $131.58 90375 RABIES IG, IM/SC $307.53 90376 RABIES IG, HEAT TREATED $338.13

More information

Injectables/Medications Administered Under the Medical Benefit Authorization NOT Required List Effective 04/01/2017

Injectables/Medications Administered Under the Medical Benefit Authorization NOT Required List Effective 04/01/2017 Injectables/Medications Administered Under the Medical Benefit Authorization NOT Required List Effective 04/01/2017 NOTES: Claims payment is subject to member eligibility, benefit coverage and current

More information

J1556 INJECTION, IMMUNE GLOBULIN (BIVIGAM) 500 MG $ J1559 INJECTION, IMMUNE GLOBULIN (HIZENTRA) 100 MG $14.364

J1556 INJECTION, IMMUNE GLOBULIN (BIVIGAM) 500 MG $ J1559 INJECTION, IMMUNE GLOBULIN (HIZENTRA) 100 MG $14.364 G0333 INITIAL 30-DAY SUPPLY AS A BENEFICIARY $57.000 J0133 INJECTION, ACYCLOVIR 5 MG $0.470 J0285 INJECTION, AMPHOTERICIN B 50 MG $10.280 J0287 INJECTION, AMPHOTERICIN B LIPID COMPLEX 10 MG $21.850 J0288

More information

DME MAC Jurisdiction C Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2018 through 03/31/2018

DME MAC Jurisdiction C Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2018 through 03/31/2018 G0333 PHARMACY DISPENSING FEE FOR INHALATION DRUG(S); INITIAL 30-DAY SUPPLY AS A BENEFICIARY $57.000 J0133 INJECTION, ACYCLOVIR 5 MG $0.068 J0285 INJECTION, AMPHOTERICIN B 50 MG $32.987 J0287 INJECTION,

More information

DME MAC Jurisdiction B Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2019 through 03/31/2019

DME MAC Jurisdiction B Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2019 through 03/31/2019 G0333 PHARMACY DISPENSING FEE FOR INHALATION DRUG(S); INITIAL 30-DAY SUPPLY AS A BENEFICIARY $57.000 J0133 INJECTION, ACYCLOVIR 5 MG $0.048 J0285 INJECTION, AMPHOTERICIN B 50 MG $31.668 J0287 INJECTION,

More information

Injections Requiring Prior Authorization

Injections Requiring Prior Authorization At VIVA Health, we strive to keep our provider network informed of any changes. Most of you may currently obtain prior authorizations for administered injections. Below is a list of injection, infusion,

More information

ELECTRONIC HEALTH RECORD (EHR) ENHANCEMENTS FOR MARCH 15, 2016 SUMMARY

ELECTRONIC HEALTH RECORD (EHR) ENHANCEMENTS FOR MARCH 15, 2016 SUMMARY ELECTRONIC HEALTH RECORD (EHR) ENHANCEMENTS FOR MARCH 15, 2016 SUMMARY Problem Opening PACS Images on ipads or ibooks has Been Fixed Changes have been made in PROD to enable user credentials to be passed

More information

Part B payment for drugs in Medicare 0

Part B payment for drugs in Medicare 0 Part B payment for drugs in Medicare 0 Introduction: The recent pilot proposal 1 on Part B drug payment from the Center for Medicare and Medicaid Innovation of CMS has met strong resistance 2 from the

More information

Drug Name. J0129 Injection, abatacept (Orencia ), 10 mg Effective 01/01/2014. J0178 Injection, aflibercept (Eylea ), 1 mg Effective 04/01/2015

Drug Name. J0129 Injection, abatacept (Orencia ), 10 mg Effective 01/01/2014. J0178 Injection, aflibercept (Eylea ), 1 mg Effective 04/01/2015 J0129 Injection, abatacept (Orencia ), 10 J0178 Injection, aflibercept (Eylea ), 1 J0256 J0257 J0585 J0586 J0587 J0588 J0597 J0641 J0717 J0800 Injection, alpha 1-proteinase inhibitor, human (Aralast NP,

More information

Drug Use Evaluation: Physician Administered Drugs (PADs)

Drug Use Evaluation: Physician Administered Drugs (PADs) Drug Use Research & Management Program OHA Division of Medical Assistance Programs 500 Summer Street NE, E35; Salem, OR 97301-1079 Phone 503-947-5220 Fax 503-947-1119 Drug Use Evaluation: Physician Administered

More information

Part B payment for drugs in Medicare: Phase 1 of CMS s proposed pilot and its impact on oncology care

Part B payment for drugs in Medicare: Phase 1 of CMS s proposed pilot and its impact on oncology care Part B payment for drugs in Medicare: Phase 1 of CMS s proposed pilot and its impact on oncology care Raina H. Jain, Stephen M. Schleicher, Coral L. Atoria, Peter B. Bach Executive Summary The recent pilot

More information

Highmark List of Procedure Codes Requiring NDC Effective 12/01/2017

Highmark List of Procedure Codes Requiring NDC Effective 12/01/2017 90378 RESPIRATORY SYNCYTIAL VIRUS, MONOCLONAL ANTIBODY, RECOMBINANT, FOR INTRAMUSCULAR USE, 50 MG, EACH C9399 Unclassified Drugs or biologicals J0129 INJECTION, ABATACEPT, 10 MG J0130 INJECTION ABCIXIMAB,

More information

Part B payment for drugs in Medicare 0

Part B payment for drugs in Medicare 0 Part B payment for drugs in Medicare 0 Introduction: The recent pilot proposal 1 on Part B drug payment from the Center for Medicare and Medicaid Innovation of CMS has met strong resistance 2 from the

More information

Primary malignant neoplasms, not lymphatic or hematopoietic. Secondary malignant neoplasms (i.e.metastatic) Malignant neoplasm, unknown site

Primary malignant neoplasms, not lymphatic or hematopoietic. Secondary malignant neoplasms (i.e.metastatic) Malignant neoplasm, unknown site Supplementary Table 1. ICD-9-CM codes used to define cancer ICD-9 Diagnosis code 140.xx-172.xx 174.xx-195.xx 196.xx 198.xx 199.xx 200.xx-208.xx Description Primary malignant neoplasms, not lymphatic or

More information

MEDICAL NECESSITY GUIDELINE

MEDICAL NECESSITY GUIDELINE PAGE: 1 of 10 IMPORTANT REMINDER This Clinical Policy has been developed by appropriately experienced and licensed health care professionals based on a thorough review and consideration of generally accepted

More information

CURRENT DRUG SHORTAGES (through February 22, 2013) CURRENT & ONGOING SHORTAGES CRITICAL SHORTAGES

CURRENT DRUG SHORTAGES (through February 22, 2013) CURRENT & ONGOING SHORTAGES CRITICAL SHORTAGES CURRENT DRUG SHORTAGES (through February 22, 2013) CRITICAL SHORTAGES Acetylcysteine Inhalation Analgesic Buprenorphine Caffeine and Ergotamine Acyclovir Meperidine Injection Adenosine Amino Acid Products

More information

Provider Administered Drug Program (PADP) and Physician Administered Drug VPSS List

Provider Administered Drug Program (PADP) and Physician Administered Drug VPSS List Provider Administered Drug Program (PADP) and Physician Administered Drug VPSS List Code Drug Name Effective and/or Term Date J0129 Injection, abatacept (Orencia ), 10 mg J0178 Injection, aflibercept (Eylea

More information

A9542 A9543 A9545 A9699 J0120 J0128 J0129 J0130

A9542 A9543 A9545 A9699 J0120 J0128 J0129 J0130 Procedure Code 90378 A9542 A9543 Procedure Description Long RESPIRATORY SYNCYTIAL VIRUS IMMUNE GLOBULIN (RSV-IGIM), FOR INTRAMUSCULAR USE, 50 MG, EACH INDIUM IN-111 IBRITUMOMAB TIUXETAN, DIAGNOSTIC, PER

More information

Active Pharmaceutical Ingredient (API) List List Updated March 1st, 2019

Active Pharmaceutical Ingredient (API) List List Updated March 1st, 2019 5-Fluorouracil 5-FU, Fluorouracil Stability Indicating HPLC-UV USP 7-keto DHEA Stability Indicating HPLC-UV Medisca Tier 1 Acetaminophen Stability Indicating HPLC-UV USP Adenosine Alprostadil PGE-1, Prostaglandin

More information

High Risk Medications

High Risk Medications Department Policy Code: D: MM-5705 Entity: Fairview Health Services Department: Home Infusion Manual: Policies & Procedures Category: Medication Management Subject: High Risk Medications Purpose: To provide

More information

Subject: Fosnetupitant-Palonosetron (Akynzeo) IV

Subject: Fosnetupitant-Palonosetron (Akynzeo) IV 09-J3000-01 Original Effective Date: 06/15/18 Reviewed: 05/09/18 Revised: 01/01/19 Subject: Fosnetupitant-Palonosetron (Akynzeo) IV THIS MEDICAL COVERAGE GUIDELINE IS NOT AN AUTHORIZATION, CERTIFICATION,

More information

Committee Approval Date: December 12, 2014 Next Review Date: July 2015

Committee Approval Date: December 12, 2014 Next Review Date: July 2015 Medication Policy Manual Policy No: dru378 Topic: Akynzeo, netupitant/palonosetron Date of Origin: December 12, 2014 Committee Approval Date: December 12, 2014 Next Review Date: July 2015 Effective Date:

More information

Provider Bulletin April 2017

Provider Bulletin April 2017 Provider Bulletin April 2017 A bulletin for the Molina Healthcare of New York, Inc. Network (Formerly Total Care, A Today s Options of New York Health Plan) Questions? Call Provider Services (877) 872-4716

More information

OFFERâ S INJECTABLES

OFFERâ S INJECTABLES A B Page 6 7 8 9 0 C 6 7 Page 8 9 0 D E Page 6 7 8 9 F Page 6 7 8 9 G H Page 6 7 8 9 I 6 7 Page 6 8 9 0 J 6 7 Page 7 K 6 7 8 9 L Page 8 6 7 8 9 0 Page 9 6 7 8 9 0 Page 0 OFFERâ S INJECTABLES Alimentary

More information

CPT / HCPCS Code. Drug Description

CPT / HCPCS Code. Drug Description coverage. Please refer to your Medical Plan GTB for To find out the cost of your drugs, please contact HMSA $0 = no 1 = Please call HMSA Customer Service 1-800-776-4672 for information. J0129 Abatacept

More information

Use of Prophylactic Growth Factors and Antimicrobials in Elderly Patients with Cancer: A

Use of Prophylactic Growth Factors and Antimicrobials in Elderly Patients with Cancer: A Supportive Care in Cancer Use of Prophylactic Growth Factors and Antimicrobials in Elderly Patients with Cancer: A Systematic Review of the Medicare Database Romina Sosa, Shuling Li, Julia T. Molony, Jiannong

More information

CPT Service Description Effective Date

CPT Service Description Effective Date Medical Oncology Program Review Code List 2 nd Quarter 2018 This list is subject to change once per quarter. Changes will be posted to the BCBSNC website at www.bcbsnc.com by the 10th day of January, April,

More information

BCBS AZ ADV PLUS * CLASSIC * PREMIER For use with members associated with the BHN Network Prior Authorization List 2015

BCBS AZ ADV PLUS * CLASSIC * PREMIER For use with members associated with the BHN Network Prior Authorization List 2015 Prior Authorization List 2015 Participating providers are responsible to furnish or arrange health care services with other participating healthcare facilities or providers. Prior authorization requests

More information

Subject: Palonosetron Hydrochloride (Aloxi )

Subject: Palonosetron Hydrochloride (Aloxi ) 09-J0000-87 Original Effective Date: 02/15/09 Reviewed: 07/09/14 Revised: 03/15/18 Subject: Palonosetron Hydrochloride (Aloxi ) THIS MEDICAL COVERAGE GUIDELINE IS NOT AN AUTHORIZATION, CERTIFICATION, EXPLANATION

More information

INJECTION, INOTUZUMAB OZOGAMICIN, 0.1 MG [BESPONSA ] [C CODES FOR FACILITY USE ONLY]

INJECTION, INOTUZUMAB OZOGAMICIN, 0.1 MG [BESPONSA ] [C CODES FOR FACILITY USE ONLY] Commercial Medical Oncology Program Review Code List 3rd Quarter 2018 This list is subject to change once per quarter. Changes will be posted to the BCBSNC website at www.bcbsnc.com by the 10th day of

More information

Public Statement: Medical Policy. Effective Date: 01/01/2012 Revision Date: 03/24/2014 Code(s): Many. Document: ARB0454:04.

Public Statement: Medical Policy. Effective Date: 01/01/2012 Revision Date: 03/24/2014 Code(s): Many. Document: ARB0454:04. ARBenefits Approval: 01/01/2012 Effective Date: 01/01/2012 Revision Date: 03/24/2014 Code(s): Many Medical Policy Title: Immunization Coverage Document: ARB0454:04 Administered by: Public Statement: 1.

More information

Guidelines on Chemotherapy-induced Nausea and Vomiting in Pediatric Cancer Patients

Guidelines on Chemotherapy-induced Nausea and Vomiting in Pediatric Cancer Patients Guidelines on Chemotherapy-induced Nausea Vomiting in Pediatric Cancer Patients COG Supportive Care Endorsed Guidelines Click here to see all the COG Supportive Care Endorsed Guidelines. DISCLAIMER For

More information

Subject: NK-1 receptor antagonist injectable therapy (Emend, Cinvanti, Varubi )

Subject: NK-1 receptor antagonist injectable therapy (Emend, Cinvanti, Varubi ) 09-J2000-60 Original Effective Date: 06/15/16 Reviewed: 04/11/18 Revised: 01/01/19 Subject: NK-1 receptor antagonist injectable therapy (Emend, Cinvanti, Varubi ) THIS MEDICAL COVERAGE GUIDELINE IS NOT

More information

Welcome. Coding uidelines Coding Guidelines Coding. Coding Guidelines Coding Guidelines. Contact Us. Edition #1 March 2018

Welcome. Coding uidelines Coding Guidelines Coding. Coding Guidelines Coding Guidelines. Contact Us. Edition #1 March 2018 Coding Guidelines Coding Guidelines uidelines Coding Guidelines Coding Coding Coding Guidelines Guidelines Coding uidelines Coding Guidelines Coding Coding Chemotherapy Guidelines and Radiation Coding

More information

LIST OF PRODUCTS INJECTIONS DRY POWDER INJECTIONS & LIQUID INJECTIONS. Therapeutic Segment. S.No Name Form Pharmacope

LIST OF PRODUCTS INJECTIONS DRY POWDER INJECTIONS & LIQUID INJECTIONS. Therapeutic Segment. S.No Name Form Pharmacope LIST OF PRODUCTS S.No Name Form Pharmacope ia Strength Therapeutic Segment ECTIONS DRY POWDER ECTIONS & LIQUID ECTIONS 1 a b Arteether 75mg/ml 150 mg/2ml & 225 mg/3ml 2 Amikacin Sulfate IP/ 100/250/500

More information

MedStar Medicare Choice Pharmacy Services

MedStar Medicare Choice Pharmacy Services Pharmacy Services 1 MedStar Medicare Choice Pharmacy Services Table of Contents At a Glance..page 2 Pharmacy Policies..page 4 Medicare Choice Pharmacy Programs..page 6 Where to Obtain Prescriptions..page

More information

Current and Emerging Therapeutic Options in the Management of Chemotherapy-Induced Nausea and Vomiting (CINV) Objectives

Current and Emerging Therapeutic Options in the Management of Chemotherapy-Induced Nausea and Vomiting (CINV) Objectives Current and Emerging Therapeutic Options in the Management of Chemotherapy-Induced Nausea and Vomiting (CINV) Susan Urba, M.D. University of Michigan Comprehensive Cancer Center Objectives Mechanisms of

More information

Managements of Chemotherpay Induded Nausea and Vomiting

Managements of Chemotherpay Induded Nausea and Vomiting REVIEW ARTICLE Managements of Chemotherpay Induded Nausea and Vomiting Department of Surgery, The Catholic University of Korea Sung Geun Kim 23 24 Sung Geun Kim Korean Journal of Clinical Oncology Summer

More information

LIST OF DRUGS THAT MAY BE COVERED UNDER YOUR MEDICAL BENEFIT

LIST OF DRUGS THAT MAY BE COVERED UNDER YOUR MEDICAL BENEFIT LIST OF DRUGS THAT MAY BE COVERED UNDER YOUR MEDICAL BENEFIT The following medications may be covered under your medical benefit if they are provided to you in your doctor s office or outpatient infusion

More information

Objective: To provide a standard procedure for the recycling of unused medication and the disposal of medicines across all BCPFT Hospital sites.

Objective: To provide a standard procedure for the recycling of unused medication and the disposal of medicines across all BCPFT Hospital sites. WARDS/DEPARTMENTS By: 0 01/09/019 1 of 3 Objective: To provide a standard procedure for the recycling of unused medication and the disposal of medicines across all BCPFT Hospital sites. Scope: All Black

More information

Description The following are synthetic cannabinoids requiring prior authorization: dronabinol (Marinol, Syndros ), nabilone (Cesamet )

Description The following are synthetic cannabinoids requiring prior authorization: dronabinol (Marinol, Syndros ), nabilone (Cesamet ) Clinical Policy: Nabilone (Cesamet), Dronabinol (Marinol, Syndros) Reference Number: CP.CPA.242 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Commercial Revision Log See Important

More information

Guideline Update on Antiemetics

Guideline Update on Antiemetics Guideline Update on Antiemetics Clinical Practice Guideline Special Announcements Please check www.asco.org/guidelines/antiemetics for current FDA alert(s) and safety announcement(s) on antiemetics 2 Introduction

More information

Outpatient Drugs Payment Policy

Outpatient Drugs Payment Policy Policy Outpatient Drugs Payment Policy Fallon Community Health Plan (FCHP) reimburses contracted providers for the provision of covered FDA-approved non-self administered drugs when given in an outpatient

More information

Drug Name Tier Drug Name Tier

Drug Name Tier Drug Name Tier Drug Name Tier Drug Name Tier ABELCET 100 MG/20 ML VIAL 4 ACETYLCYSTEINE 10% VIAL 2 ACETYLCYSTEINE 20% VIAL 2 ACYCLOVIR 1,000 MG/20 ML VIAL 2 ACYCLOVIR 500 MG/10 ML VIAL 2 ADRUCIL 500 MG/10 ML VIAL 2 ALBUTEROL

More information

Haematology, Oncology and Palliative Care Directorate.

Haematology, Oncology and Palliative Care Directorate. Anticancer Treatment for Administration on the Somerset Mobile Chemotherapy Unit The table below details the suitability of different types of anticancer treatment for administration on the Somerset Mobile

More information

Dry injection list 1-Ceftriaxone 1000 mg & Sulbactam 500 mg Inj. 2-Ceftriaxone 500 mg & Sulbactam 250 mg Inj.

Dry injection list 1-Ceftriaxone 1000 mg & Sulbactam 500 mg Inj. 2-Ceftriaxone 500 mg & Sulbactam 250 mg Inj. Dry injection list 1-Ceftriaxone 1000 mg & Sulbactam 500 mg Inj. 2-Ceftriaxone 500 mg & Sulbactam 250 mg Inj. 3-Ceftriaxone 250mg & Sulbactam 125mg Inj. 4-Ceftriaxone 125mg & Sulbactam 62.5mg Inj. 5-Rabeprazole

More information

West of Scotland Cancer Network Guideline for Managing Chemotherapy Induced Nausea and Vomiting

West of Scotland Cancer Network Guideline for Managing Chemotherapy Induced Nausea and Vomiting West of Scotland Cancer Network Guideline for Managing Chemotherapy Induced Nausea and Vomiting Definitions Acute nausea and vomiting Delayed nausea and vomiting Anticipatory nausea and vomiting Initial

More information

GUIDELINES FOR ANTIEMETIC USE IN ONCOLOGY SUMMARY CLASSIFICATION

GUIDELINES FOR ANTIEMETIC USE IN ONCOLOGY SUMMARY CLASSIFICATION GUIDELINES FOR ANTIEMETIC USE IN ONCOLOGY SUMMARY More than half of all cancer patients experience nausea or vomiting during the course of their treatment. If nausea or vomiting becomes severe enough,

More information

SCI. SickKids-Caribbean Initiative Enhancing Capacity for Care in Paediatric Cancer and Blood Disorders

SCI. SickKids-Caribbean Initiative Enhancing Capacity for Care in Paediatric Cancer and Blood Disorders 1.0 Introduction The (SCI) is a not-for-profit collaboration between the Hospital for Sick Children (SickKids), Toronto, Canada, and seven Caribbean health care institutions across six countries that strive

More information

The administration of covered immunizations and vaccines also is covered.

The administration of covered immunizations and vaccines also is covered. Covered Benefit: Vaccines & Immunization Definitions: CMP Published: Yes No CMP Link: CPG Link: Pediatric, Adolescent and Adult Routine Preventative Services Immunizations and vaccinations for treatment

More information

IHCP banner page INDIANA HEALTH COVERAGE PROGRAMS BR FEBRUARY 16, 2016

IHCP banner page INDIANA HEALTH COVERAGE PROGRAMS BR FEBRUARY 16, 2016 IHCP banner page INDIANA HEALTH COVERAGE PROGRAMS BR201607 FEBRUARY 16, 2016 HCPCS code J1458 linked to revenue code 636 Effective March 16, 2016, the Indiana Health Coverage Programs (IHCP) will link

More information

Guidelines for the Use of Anti-Emetics with Chemotherapy

Guidelines for the Use of Anti-Emetics with Chemotherapy Guidelines for the Use of Anti-Emetics with The purpose of this document is to provide guidance on the rational use of anti-emetics for prevention and treatment of chemotherapy-induced nausea and vomiting

More information

The administration of covered immunizations and vaccines also is covered.

The administration of covered immunizations and vaccines also is covered. Covered Benefit: Immunization & Vaccines Definitions: CMP Published: Yes No CMP Link: CPG Link: Pediatric, Adolescent and Adult Routine Preventative Services Immunizations and vaccinations for treatment

More information

Prevention and Management of chemo-and radiotherapy-induced nausea and vomiting

Prevention and Management of chemo-and radiotherapy-induced nausea and vomiting Prevention and Management of chemo-and radiotherapy-induced nausea and vomiting Focusing on the updated MASCC/ESMO guidelines Karin Jordan Department of Hematology and Oncology, University of Heidelberg

More information

From the joint NHS pharmacy technical services groups, for distribution via local NHS network groups:- Dear NHS Colleague,

From the joint NHS pharmacy technical services groups, for distribution via local NHS network groups:- Dear NHS Colleague, From the joint NHS pharmacy technical services groups, for distribution via local NHS network groups:- Dear NHS Colleague, Supporting document for NPSA Injectables Patient Safety Alert Attached is a document

More information

Alaris System Profile Report RELEASED. Stepdown. VUMC - 3/18/ :20 Page 1 of 19 VUMC O, 018d997b6-R

Alaris System Profile Report RELEASED. Stepdown. VUMC - 3/18/ :20 Page 1 of 19 VUMC O, 018d997b6-R Alaris System Profile Report RELEASED Stepdown VUMC - 3/18/2013 09:20 Page 1 of 19 1. Current Data Set Status Data Set Name Hospital Name Data Set ID Data Set Status VUMC 9.4 2013 O VUMC 018d997b6-R Released

More information

DOXOrubicin, Cyclophosphamide (AC 60/600) 21 day followed by weekly PACLitaxel (80) Therapy (AC-T) 261 CARBOplatin (AUC4-6) Monotherapy-21 days

DOXOrubicin, Cyclophosphamide (AC 60/600) 21 day followed by weekly PACLitaxel (80) Therapy (AC-T) 261 CARBOplatin (AUC4-6) Monotherapy-21 days Last updated Oct 17, 2018 Tumour Group Protocol Number Protocol Name on NCCP website Breast 200 Trastuzumab (IV) Monotherapy 21 days 201 Trastuzumab (IV) Monotherapy 7 days 202 DOCEtaxel Monotherapy 100mg/m2

More information

Medicare Part B Covered Medications

Medicare Part B Covered Medications This table provides a reference guide for the most frequent Part B/D coverage determination scenarios facing Part D plans and Part D pharmacy providers. It does not address all potential situations. For

More information

1 17 ACITRETIN 10MG CAP 20, ,000 14,000 4, ACITRETIN 25MG CAP 50, ,000 35,000 10,000

1 17 ACITRETIN 10MG CAP 20, ,000 14,000 4, ACITRETIN 25MG CAP 50, ,000 35,000 10,000 ردیف کد ژنریک نام ژنریک مبلغ پوشش وزارت بهداشت مبلغ پوشش بیمه مبلغ پرداخت بیمار درصد پرداخت بیمار قیمت اعالمی وزارت بهداشت نام تجاری 1 17 ACITRETIN 10MG CAP 20,000 10.0 2,000 14,000 4,000 2 18 ACITRETIN

More information

MDwise Self-Administered Codes for Medical

MDwise Self-Administered Codes for Medical The following codes are associated with medications that can be self-administered by the patient or a caregiver. As a result, MDwise will transfer coverage of these self-administered medications exclusively

More information

Rajasthan Medical Services Corporation Limited, Jaipur

Rajasthan Medical Services Corporation Limited, Jaipur Rajasthan Medical Services Corporation Limited, Jaipur List of Drugs- Purchase order placed to successful Bidders Tendered on 05/07/2011 S.No. Name of Drug 1 Atropine Sulphate Injection 0.6 mg /ml (SC/IM/IV

More information

LIST OF DRUGS / MEDICINES ITEMS FOR THE YEAR (Non-Prequalified Items) A: Injection Antimicrobials Sr. No.

LIST OF DRUGS / MEDICINES ITEMS FOR THE YEAR (Non-Prequalified Items) A: Injection Antimicrobials Sr. No. LIST OF DRUGS / MEDICINES ITEMS FOR THE YEAR 2017-2018 (Non-Prequalified Items) A: Injection Antimicrobials Sr. 1 Amphotericin B vial of 50mg with wfi individually packed in carton with 2 Artemether 80mg/ml

More information

Adverse effects of anticancer drugs (Antimetabolites agents, Alkylating agents, Antimicrotubule agents, Miscellaneous agents, Immune therapies and

Adverse effects of anticancer drugs (Antimetabolites agents, Alkylating agents, Antimicrotubule agents, Miscellaneous agents, Immune therapies and 35 Adverse effects of anticancer drugs (Antimetabolites agents, Alkylating agents, Antimicrotubule agents, Miscellaneous agents, Immune therapies and Biologically directed therapies ) 1 1- Nausea and vomiting

More information

Exhibit B United States Patent Application 20020012663 Kind Code A1 Waksal, Harlan W. January 31, 2002 Treatment of refractory human tumors with epidermal growth factor receptor antagonists Abstract A

More information

methylergonovine 0.2 mg/ml (1 ml) injection solution enoxaparin 100 mg/ml subcutaneous syringe

methylergonovine 0.2 mg/ml (1 ml) injection solution enoxaparin 100 mg/ml subcutaneous syringe Px Code Generic Name NDC Unit Price 2580001 phenylephrine 1 mg/10 ml (100 mcg/ml) in 0.9 % sod.chloride IV syringe 69374095710 136.29 2580001 phenylephrine 1 mg/10 ml (100 mcg/ml) in 0.9 % sod.chloride

More information

ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced

ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced Class Medicine Name Nappi Strength Form Size Route Abiraterone Acetate ZYTIGA

More information

Customer Service: Shop online at

Customer Service: Shop online at Effective May 1, 2017 Item Number Changes for Pharmaceuticals Due to changes in regulatory requirements, effective May 1, 2017, some of our pharmaceuticals' units of sale will change. The table below outlines

More information

HCPCS Code/ generic (Brand) Name J7506. J8520 capecitabine (Xeloda) 1. J8521 capecitabine. J8530 cyclophosphamide. (Cytoxan) 1

HCPCS Code/ generic (Brand) Name J7506. J8520 capecitabine (Xeloda) 1. J8521 capecitabine. J8530 cyclophosphamide. (Cytoxan) 1 drug and administration compendia Current Price () J7506 Prednisone, oral, per 5 mg 12/1/07 $0.07 $0.19 N/A prednisone 2 J8520 capecitabine (Xeloda) 1 Capecitabine, oral, 150 mg 8/1/07 $5.79 $4.59 N/A

More information

Active Pharmaceutical Ingredient (API) List List Updated 03/08/2018

Active Pharmaceutical Ingredient (API) List List Updated 03/08/2018 5-Fluorouracil HPLC/ UHPLC Yes USP 4017 30 5mL 2 7-keto DHEA HPLC/ UHPLC Yes Medisca 4258 180 5mL 1 Acetaminophen HPLC/ UHPLC Yes USP 4406 5mL 2 Acetylcysteine HPLC/ UHPLC Yes USP 4255 60 5mL 1 Adenosine

More information

ANTIEMETICS UTILIZATION MANAGEMENT CRITERIA

ANTIEMETICS UTILIZATION MANAGEMENT CRITERIA ANTIEMETICS [Akynzeo, Anzemet, Cesamet, Emend, Sancuso, Varubi, Zuplenz ] DRUG CLASS: UTILIZATION MANAGEMENT CRITERIA 5-HT 3 Receptor Antagonists 5-HT 3 Receptor Antagonist and Substance P/Neurokinin (NK

More information

UHA Medical Drug List

UHA Medical Drug List for pricing information The following is a list of drugs that are covered under the medical benefit. The cost share may be dependent on the diagnosis and/or the dose prescribed by your physician. Customer

More information

Protocol Number Tumour Group Protocol Name on NCCP website 22/02/ Lung Afatinib Monotherapy 244 Gastrointestinal Regorafenib Monotherapy

Protocol Number Tumour Group Protocol Name on NCCP website 22/02/ Lung Afatinib Monotherapy 244 Gastrointestinal Regorafenib Monotherapy Last Updated 22-Feb-18 Date of last update Protocol Number Tumour Group Protocol Name on NCCP website 22/02/2018 221 Afatinib Monotherapy 244 Gastrointestinal Regorafenib Monotherapy 249 Gynaecology Intrathecal

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: Reference Number: CP.CPA.223 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Commercial Revision Log See Important Reminder at the end of this policy for important regulatory

More information

Riesbeck's Pharmacy Reward Club Generic Medication List February 2018 $4 30 Day Supply

Riesbeck's Pharmacy Reward Club Generic Medication List February 2018 $4 30 Day Supply Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Inj 50MG/ML 1 3 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml

More information

APPHON/ROPPHA Guideline for the Prevention and Management of Chemotherapy Induced Nausea and Vomiting in Children with Cancer

APPHON/ROPPHA Guideline for the Prevention and Management of Chemotherapy Induced Nausea and Vomiting in Children with Cancer APPHON/ROPPHA Guideline for the Prevention and Management of Chemotherapy Induced Nausea and Vomiting in Children with Cancer 5850/5980 University Avenue, PO Box 9700, Halifax, N.S. B3K 6R8 PEDIATRIC HEMATOLOGY/ONCOLOGY

More information

Product List Finished Dosage Forms (FDF) B2B Business

Product List Finished Dosage Forms (FDF) B2B Business Product List 2017 Finished Dosage Forms (FDF) B2B Business Anaesthetics Dermatology Lidocaine Lidocaine and Prilocaine Dexmedetomidine Hydrochloride Anti-Infectives Amoxicillin Trihydrate and Potassium

More information

Adult Intravenous Systemic Anticancer Therapy (SACT) Section A. SUMMARY of SCHEME QIPP Reference

Adult Intravenous Systemic Anticancer Therapy (SACT) Section A. SUMMARY of SCHEME QIPP Reference CA2 Nationally standardised Dose banding for Adult Intravenous Anticancer Therapy (SACT) Scheme Name CA2: Nationally Standardised Dose Banding for Adult Intravenous Systemic Anticancer Therapy (SACT) Section

More information

Protocol Number Intrathecal Methotrexate for CNS 01/02/2018 Prophylaxis in GTN Gynaecology 249

Protocol Number Intrathecal Methotrexate for CNS 01/02/2018 Prophylaxis in GTN Gynaecology 249 Last updated Feb 9, 2018 Revision due Protocol Name on NCCP website Tumour Group Protocol Number Intrathecal Methotrexate for CNS 01/02/2018 Prophylaxis in GTN Gynaecology 249 Two Day Etoposide CISplatin

More information

VMG Pharmaceuticals Pvt. Ltd.

VMG Pharmaceuticals Pvt. Ltd. S. No. Product Name S trength Dos age form Oncology 1 A nastrazole 1 mg Tablets 2 Bicalutamide 50 mg Tablets 3 Bleomycin 15units,30units Injection 4 Bortezomib 3.5 mg Injection 5 Capecitabine 500 mg Tablets

More information

MASCC Guidelines for Antiemetic control: An update

MASCC Guidelines for Antiemetic control: An update MASCC / ISOO 17 th International Symposium Supportive Care in Cancer June 30 July 2, 2005 / Geneva, Switzerland MASCC Guidelines for Antiemetic control: An update Sussanne Börjeson, RN, PhD Linköping University,

More information

Hazardous Medication List

Hazardous Medication List Hazardous Medication List REDUCING OCCUPATIONAL EXPOSURE TO HAZARDOUS MEDICATION FOR ALL STAFF Table of Contents Hazardous Medication List Key Points... 1 Hazardous Medication List... 2 Special Handling

More information

Guideline for Classification of the Acute Emetogenic Potential of Antineoplastic Medication in Pediatric Cancer Patients

Guideline for Classification of the Acute Emetogenic Potential of Antineoplastic Medication in Pediatric Cancer Patients Guideline for Classification of the Acute Emetogenic Potential of Antineoplastic Medication in Pediatric Cancer Patients POGO Antineoplastic Induced Nausea and Vomiting Guideline Development Panel: L.

More information

1 ml) (100 x. 10 ml)

1 ml) (100 x. 10 ml) SCHEDULE COPY NICIPAL CORPORATION OF GREATER MUM NTRAL PURCHASE AUTHORITY DEPARTME SCHEDULE I OF 2010-2011 INJECTIONS & SERA VACCINES CONTRACT PERIOD : 1-1-2010 To 31-12-2011 Item Description Quantity

More information

CURRENT DRUG SHORTAGES (through October 14, 2014)

CURRENT DRUG SHORTAGES (through October 14, 2014) CRITICAL SHORTAGES at Methodist Ammonium Chloride Injection Analgesic Buprenorphine Sublingual Tablets Azathioprine Injection Buprenorphine Injection Barium Sulfate Suspension Butorphanol Becapler Gel

More information

Northern Cancer Alliance

Northern Cancer Alliance Northern Cancer Alliance Anti-emetic Guidelines for Chemotherapy Induced Nausea and Vomiting (CINV) Adult Oncology & Haematology Document Control Document Title: Antiemetic Guidelines for CINV NESCN v2.2

More information

PA Category Name Code(s) Additional Notes ABA. Applied Behavioral Analysis stage 3*

PA Category Name Code(s) Additional Notes ABA. Applied Behavioral Analysis stage 3* ABA BEHAVIORAL HEALTH CHEMICAL DEPENDENCY Applied Behavioral Analysis stage 3* Neuropsychological Testing Chemical Dependency/Substance Abuse* (MA Only) 0373T H2020 96116 96112 96113 96121 96130 96131

More information

To help doctors give their patients the best possible care, the American

To help doctors give their patients the best possible care, the American Patient Information Resources from ASCO What to Know ASCO s Guideline on Preventing Vomiting Caused by Cancer Treatment SEPTEMBER 2011 KEY MESSAGES The risk of nausea and vomiting depends on the specific

More information

Release of the 2017/18 Invitation to Tender

Release of the 2017/18 Invitation to Tender 2 November 2017 Release of the 2017/18 Invitation to Tender The 2017/18 Invitation to Tender (2017/18 ITT) has been distributed today. If you have already registered your e-mail address with PHARMAC s

More information

Riesbeck's Pharmacy Reward Club Generic Medication List October 2017

Riesbeck's Pharmacy Reward Club Generic Medication List October 2017 Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Inj 50MG/ML 1 3 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml

More information

INJECTABLE MEDICINES. Resources, Links or Additional Information. J Code Brand Names Generic names Prior Authorization or Restrictions

INJECTABLE MEDICINES. Resources, Links or Additional Information. J Code Brand Names Generic names Prior Authorization or Restrictions J9190 5-FU fluorouracil None. J0401 ABILIFY MAINTENA aripiprazole i.v. J9264 ABRAXANE paclitaxel protein bound J3262 ACTEMRA IV tocilizumab Yes, through Navitus. Restricted to (in at least consultation

More information

RAHF PFM ALPHANINE SD COAGULATION FACTOR IX J7193 COAGULATION FACTOR IX (RFIXFC)

RAHF PFM ALPHANINE SD COAGULATION FACTOR IX J7193 COAGULATION FACTOR IX (RFIXFC) INFECTIOUS DISEASE ACTIMMUNE INTERFERON GAMMA 1B J9216 ADVATE RAHF PFM ONCOLOGY ORAL AFINITOR EVEROLIMUS J7527 INFECTIOUS DISEASE ALFERON N INTERFERON ALFA N3 J9215 ALPHANATE VWF J7186 ALPHANINE SD J7193

More information

Billing for Infusion Services in an Outpatient Neurology Clinic. Christine Mann, MBA Director of Infusion Services Dent Neurologic Institute

Billing for Infusion Services in an Outpatient Neurology Clinic. Christine Mann, MBA Director of Infusion Services Dent Neurologic Institute Billing for Infusion Services in an Outpatient Neurology Clinic Christine Mann, MBA Director of Infusion Services Dent Neurologic Institute Overview of Infusion Billing Codes Current Procedure Terminology

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Zofran, Zuplenz) Reference Number: CP.CPA.173 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Medicaid Medi-Cal Revision Log See Important Reminder at the end of this

More information

NOTICES DEPARTMENT OF HEALTH

NOTICES DEPARTMENT OF HEALTH NOTICES DEPARTMENT OF HEALTH Approved Drugs for ALS Ambulance Services [42 Pa.B. 4229] [Saturday, July 7, 2012] Under 28 Pa. Code 1005.11(b) (relating to drug use, control and security), the following

More information